TY - JOUR
T1 - National Institute for the Infectious Diseases “L. Spallanzani”, IRCCS. Recommendations for COVID-19 clinical management
AU - INMI COVID-19 Treatment Group (ICOTREG)
AU - Nicastri, Emanuele
AU - Petrosillo, Nicola
AU - Bartoli, Tommaso Ascoli
AU - Lepore, Luciana
AU - Mondi, Annalisa
AU - Palmieri, Fabrizio
AU - D’Offizi, Gianpiero
AU - Marchioni, Luisa
AU - Murachelli, Silvia
AU - Ippolito, Giuseppe
AU - Antinori, Andrea
N1 - Publisher Copyright:
© Copyright: the Author(s), 2020.
PY - 2020/2/20
Y1 - 2020/2/20
N2 - On January 9 2020, the World Health Organization (WHO) declared the identification, by Chinese Health authorities, of a novel coronavirus, further classified as SARS-CoV-2 responsible of a disease (COVID-19) ranging from asymptomatic cases to severe respiratory involvement. On March 9 2020, WHO declared COVID-19 a global pandemic. Italy is the second most affected country by COVID-19 infection after China. The “L. Spallanzani” National Institute for the Infectious Diseases, IRCCS, Rome, Italy, has been the first Italian hospital to admit and manage patients affected by COVID-19. Hereby, we show our recommendations for the management of COVID-19 patients, based on very limited clinical evidences; they should be considered as expert opinions, which may be modified according to newly produced literature data. n-
AB - On January 9 2020, the World Health Organization (WHO) declared the identification, by Chinese Health authorities, of a novel coronavirus, further classified as SARS-CoV-2 responsible of a disease (COVID-19) ranging from asymptomatic cases to severe respiratory involvement. On March 9 2020, WHO declared COVID-19 a global pandemic. Italy is the second most affected country by COVID-19 infection after China. The “L. Spallanzani” National Institute for the Infectious Diseases, IRCCS, Rome, Italy, has been the first Italian hospital to admit and manage patients affected by COVID-19. Hereby, we show our recommendations for the management of COVID-19 patients, based on very limited clinical evidences; they should be considered as expert opinions, which may be modified according to newly produced literature data. n-
KW - COVID-19
KW - SARS-CoV-2
KW - Treatment
UR - http://www.scopus.com/inward/record.url?scp=85089704281&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85089704281&partnerID=8YFLogxK
U2 - 10.4081/IDR.2020.8543
DO - 10.4081/IDR.2020.8543
M3 - Article
AN - SCOPUS:85089704281
VL - 12
SP - 3
EP - 9
JO - Infectious Disease Reports
JF - Infectious Disease Reports
SN - 2036-7430
IS - 1
ER -